On the same day Sarepta Therapeutics Inc. welcomed politicians and patients to the grand opening of its Columbus research hub, the company started the final clinical trial before seeking approval of a potential treatment for a fatal form of muscular dystrophy.
The therapy is one of several invented or co-invented at Nationwide Children’s Hospital by Louise Rodino-Klapac, who today is Sarepta’s Columbus-based executive vice president and chief scientific officer. The hospital also led Sarepta’s preparatory clinical trials.
Click here to read the complete story.
Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.
Originally published October 6, 2021.